Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4.
Lancet. 2020.
PMID: 32896291
Free PMC article.
Clinical Trial.
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
Logunov DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV.
Logunov DY, et al. Among authors: tukhvatullin ai.
Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.
Lancet. 2020.
PMID: 32971043
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite